CMA accepts Atleos remedy in principle and NCR Atleos stock trades at EUR 40.70

Published on 10/08/2026 at 20:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue was USD 1.10 billion, with 70.00 percent recurring. NCR Atleos stock stood at EUR 40.70 on October 8, 2026 versus EUR 40.50.

Key points in brief

The UK Competition and Markets Authority accepted in principle a remedy for Brink's planned acquisition of NCR Atleos on October 8, 2026.
The transaction remains targeted for early in the first quarter of 2027, with USD 200.00 million in annual run-rate synergies expected within three years of closing.
NCR Atleos reported USD 1.10 billion in second-quarter revenue, with 70.00 percent from recurring revenue streams.
NCR Atleos stock was at EUR 40.70 at Lang & Schwarz on October 8, 2026, plus 0.49 percent versus the EUR 40.50 prior close.

NATL, US63001N1063, Illustration mit AI erstellt.

CMA acceptance in principle of Brink's proposed remedy puts NCR Atleos stock (ISIN US63001N1063) at the center of a regulatory milestone, while the shares were trading at EUR 40.70 at Lang & Schwarz after hours on October 8, 2026. The Competition and Markets Authority accepted the remedy for Brink's planned acquisition of NCR Atleos, which remains targeted to close early in the first quarter of 2027, GlobeNewswire reported on October 8, 2026.

What does the remedy change?

The proposed solution involves the sale of Brink's NoteMachine business and its UK TestLink business to address competition concerns. The CMA said Brink's and NCR Atleos together operate more than 50.00 percent of UK cash machines and will seek feedback before deciding whether to clear the transaction, according to the Competition and Markets Authority on October 8, 2026.

Three deal milestones

On June 30, 2026, shareholders approved the acquisition, with completion expected by the end of the first quarter of 2027, according to Simplify. On September 30, 2026, Brink's said the proposed UK divestiture would not change its expected USD 200.00 million in annual run-rate cost synergies within three years of closing, GlobeNewswire reported.

On October 8, 2026, the CMA accepted the remedy in principle, leaving the proposed early first-quarter 2027 closing as the next major transaction milestone. The structure reduces one regulatory obstacle but leaves the final approval process and buyer selection for the divested UK assets outstanding.

Revenue brings a second anchor

NCR Atleos reported USD 1.10 billion in revenue for the second quarter of 2026, flat year over year, with 70.00 percent from recurring revenue streams. Net income attributable to Atleos reached USD 65.00 million, up 67.00 percent year over year, according to Simplify.

Price holds near the daily close

The NYSE-listed company was last at USD 45.60 on October 8, 2026 at 2:03 p.m. EDT, with a market capitalization of USD 3.4 billion and a 52-week range of USD 33.31 to USD 48.50. At Lang & Schwarz, the stock was trading at EUR 40.70 on October 8, 2026 at 8:02 p.m. CEST, plus 0.49 percent versus the prior close of EUR 40.50 on October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of NCR Atleos stock.